首页> 外国专利> Stearoyl ammonia 4,5-c nitrous oxide (OA) compounds and their use in cancer treatment

Stearoyl ammonia 4,5-c nitrous oxide (OA) compounds and their use in cancer treatment

机译:硬脂酰氨[4,5-c]一氧化二氮(OA)化合物及其在癌症治疗中的用途

摘要

Narrative reports generally refer to formula (I): (I) and the pharmaceutically acceptable salts of these compounds, wherein R1 has the meaning defined in this document. The descriptive report also mentions the use of formula (I) and formula salts to treat or prevent atmospheric media diseases, including cancer. The explanatory report also refers to pharmaceutical compounds containing alternatives to pyridan [4,5-c] quinine-2-ona and acceptable salts on drugs, as well as kits containing such compounds and salts.
机译:叙述性报道通常涉及式(I):(I)以及这些化合物的药学上可接受的盐,其中R 1具有本文定义的含义。描述性报告还提到了使用式(I)和式盐来治疗或预防大气介质疾病,包括癌症。解释性报告还涉及含有吡喃并[4,5-c]奎宁-2-ona替代品和药物可接受盐的药物化合物,以及含有此类化合物和盐的试剂盒。

著录项

  • 公开/公告号CO2019010029A2

    专利类型

  • 公开/公告日2019-09-30

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号CO20190010029

  • 申请日2019-09-16

  • 分类号C07D471/04;A61K31/437;A61P35;

  • 国家 CO

  • 入库时间 2022-08-21 12:02:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号